✦ LIBER ✦

P539 Dose intensification with anti-TNF agents in inflammatory bowel disease – a secondary care experience

✍ Scribed by Kothegal Marimahadevappa, G.; Limdi, J.K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P386 Refractory inflammatory bowel disea

✍ Gubonina, I.; Pershko, A.; Dragun, A. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 116 KB

P381 Predictors and frequency of anti-TN

✍ Viazis, N.; Koukouratos, T.; Anastasiou, J.; Saprikis, E.; Kechagias, G.; Katopo 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 48 KB

P489 How often is dose escalation needed

✍ Viazis, N.; Koukouratos, T.; Saprikis, E.; Al-Odat, M.; Anastasopoulos, E.; Zach 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Induction of psoriasis with anti-TNF age

✍ Iván Guerra; Alicia Algaba; José Lázaro Pérez-Calle; María Chaparro; Ignacio Mar 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 261 KB

P289 - FoxP3+CD4+ cells in patients with

✍ L. Guidi; C. Felice; M. Marzo; A. Procoli; G. Bonanno; A. Papa; I. De Vitis; S. 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 48 KB

P.224 FECAL CALPROTECTIN LEVELS AFTER IN

✍ M. Marzo; A. Armuzzi; C. Felice; G. Andrisani; L. Sparano; G. Vitale; D. Puglies 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB